Stephen Taub Premium Ginkgo Bioworks’ SPAC Success Is Good News for These Hedge Funds The biotech company had a strong first day of trading and is so far bucking the trend of underperformance for recently merged special purpose acquisition companies. Stephen Taub September 20, 2021 A Ginkgo Bioworks facility in Boston. (Scott Eisen/Bloomberg)